Back to Candriam S.C.A. Candriam S.C.A.

CYTKCYTK
23 quarters

Position history for Candriam S.C.A.Candriam S.C.A.'s holdings in CYTOKINETICS INC

Candriam S.C.A. holds 443,066 shares of CYTK (CYTOKINETICS INC), worth $37.7M as of 2026-Q2. The position was increased (+32.2% shares). CYTK represents 0.2% of Candriam S.C.A.'s portfolio.

Current Value

$37.7M

Current Shares

443,066

Total Value Change

+$34.7M

Total Shares Change

+302,841

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
443,066
+32.2%
$37.7M0.2%$85.19
44
2026-Q1
Increased
335,208
+128.6%
$22.1M0.1%$60.72
55
2025-Q4
New
146,631
-
$9.3M0.0%$61.37
38
2025-Q2
Exited
0
-100.0%
$00.0%$33.16
0
2025-Q1
Decreased
145,191
-14.9%
$5.8M0.0%$43.19
0
2024-Q4
Decreased
170,560
-4.8%
$8M0.0%$47.15
0
2024-Q3
Unchanged
179,200
0.0%
$9.5M0.1%$52.34
0
2024-Q2
Decreased
179,200
-63.6%
$9.7M0.1%$54.18
0
2024-Q1
Increased
493,029
+84.5%
$34.6M0.2%$70.11
54
2023-Q4
Decreased
267,240
-46.9%
$22.3M0.2%$83.49
0
2023-Q3
Decreased
503,240
-6.5%
$14.8M0.1%$29.46
0
2023-Q2
Unchanged
538,240
0.0%
$17.6M0.1%$32.75
0
2023-Q1
Increased
538,240
+7.0%
$17.4M0.1%$34.21
36
2022-Q4
Unchanged
503,240
0.0%
$23.1M0.2%$45.82
0
2022-Q3
Decreased
503,240
-3.3%
$24.4M0.2%$48.93
0
2022-Q2
Decreased
520,476
-18.7%
$20.4M0.2%$48.74
0
2022-Q1
Increased
640,228
+24.7%
$23.6M0.2%$36.53
42
2021-Q4
Unchanged
513,344
0.0%
$23.4M0.1%$45.60
0
2021-Q3
Unchanged
513,344
0.0%
$18.3M0.1%$33.59
0
2021-Q2
Increased
513,344
+36.6%
$10.2M0.1%$21.12
36
2021-Q1
Unchanged
375,853
0.0%
$7.5M0.1%$22.33
0
2020-Q4
Increased
375,853
+168.0%
$7.8M0.1%$20.36
44
2020-Q3
New
140,225
-
$3M0.0%$22.33
37

Other major holders of CYTK: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used